Selank
Selank
Selank is a synthetic peptide analogue researched for its anxiolytic and nootropic effects in humans. Clinical studies demonstrate significant reductions in anxiety alongside improvements in memory, attention and mood — with a key advantage over conventional anxiolytics: research confirms Selank produces these effects without sedation, physical dependency or withdrawal symptoms. It is registered as a licensed pharmaceutical in Russia and Ukraine, combining anxiolytic and cognitive-enhancing benefits in a single well-characterised compound.
Supplied as research-grade lyophilised peptide. Available in vial, pen and nasal spray formats. For research purposes only.
Research Stack Builder
Build Your Research Stack
Curated combinations based on what researchers actually stack — backed by published data, priced to save.
Stack with Selank
Why researchers stack these
- 01Anxiolytic + stimulatory cognitive balance
- 02NAD+ powers enhanced neuronal output
- 03Systemic repair alongside brain health
Full research context
Selank reduces anxiety and enhances cognitive function through GABA modulation and neuroimmune pathways — no sedation, no dependency risk. Semax provides the complementary stimulatory input via BDNF and cortical processing speed. Together they are described consistently in research as producing balanced cognitive enhancement that neither achieves alone. NAD+ provides the cellular energy substrate. GHK-Cu is frequently added by researchers studying the systemic benefits of running collagen support and repair gene modulation alongside a cognitive protocol.
Recovery & Repair Protocol
The most studied peptide combination for tissue repair, injury recovery & musculoskeletal healing
Why researchers stack these
- 01Non-competing structural repair pathways
- 02BPC-157 angiogenesis + TB-500 satellite cell activation
- 03GHK-Cu adds the extracellular matrix layer both lack
Full research context
BPC-157 and TB-500 are the two most frequently co-researched repair peptides in published literature, acting through complementary mechanisms — BPC-157 via nitric oxide pathways and angiogenesis, TB-500 via actin-sequestering and satellite cell activation. GHK-Cu rounds out the stack by supporting collagen synthesis and the extracellular matrix that both compounds do not directly address, while reducing the oxidative load that slows tissue recovery.
Metabolic & Body Recomposition
Most popular Peptide Pal stack — two non-competing fat loss axes with skin integrity support
Why researchers stack these
- 01GLP-1 triple agonism + GH axis — two distinct fat loss pathways
- 02Skin integrity preserved throughout recomposition
- 03Most purchased together on Peptide Pal
Full research context
Retatrutide and Tesamorelin address body composition through two non-competing mechanisms. Retatrutide's triple receptor agonism drives broad metabolic improvement and appetite regulation; Tesamorelin is FDA-approved for visceral adipose reduction through the growth hormone axis — a distinct mechanism. GHK-Cu supports skin integrity during recomposition; rapid fat loss without collagen support produces visible skin laxity that is far harder to address after the fact.
Cognitive Performance Stack
Neuropeptides studied for synergistic cognitive enhancement, focus & stress resilience — no sedation
Why researchers stack these
- 01BDNF stimulation balanced by GABA modulation
- 02Focus without anxiety — three non-competing pathways
- 03NAD+ fuels the neuronal energy demand
Full research context
Semax and Selank are registered pharmaceuticals with distinct mechanisms. Semax drives BDNF upregulation and cortical processing speed; Selank reduces the stress-induced cognitive interference that can blunt that effect, without sedation or dependency. NAD+ provides the cellular energy substrate that enhanced neuronal activity demands — researchers consistently report that this combination delivers balanced cognitive performance that neither compound achieves alone.
Skin & Glow Protocol
Collagen synthesis, antioxidant protection & melanin research in one comprehensive skin stack
Why researchers stack these
- 01Collagen, antioxidant & pigmentation — three skin pillars
- 02Tyrosinase inhibition counterbalances MC1R agonism for pathway research
- 03Structural integrity maintained alongside brightening
Full research context
GHK-Cu stimulates collagen synthesis and modulates over 4,000 genes involved in skin repair and inflammatory control — addressing the structural layer. Glutathione reduces oxidative stress and inhibits tyrosinase, producing measurable skin brightening with 30–35% tissue GSH increases confirmed in human RCTs. MT2 drives eumelanin synthesis via MC1R agonism, and researchers frequently combine it with Glutathione to study the interplay between melanocortin-driven pigmentation and tyrosinase inhibition simultaneously. Together these three represent the most comprehensive skin research protocol available.
Cellular Longevity Protocol
Three compounds that decline together with age — combined restoration for mitochondrial & cellular health
Why researchers stack these
- 01All three decline together with age — parallel restoration
- 02Mitochondrial energy, AMPK signalling & antioxidant protection
- 03Most complete cellular longevity protocol available
Full research context
NAD+, MOTS-c, and glutathione all decline measurably with age through parallel but distinct pathways. NAD+ restores sirtuin and PARP function essential for mitochondrial biogenesis and DNA repair — declining up to 50% by age 60. MOTS-c is the mitochondria-derived peptide that activates AMPK signalling and declines alongside NAD+; their combined restoration is the most researched longevity intervention. Glutathione provides the antioxidant protection that prevents cellular damage during the heightened metabolic activity that NAD+ and MOTS-c restoration drives — completing what researchers describe as the foundational cellular longevity triad.
Research & Studies
Peer-reviewed research supporting Selank
Selank Demonstrates Anxiolytic and Cognitive Benefits in Human Patients with Anxiety Disorders
Clinical evaluation of Selank in human patients diagnosed with generalised anxiety disorder and neurasthenia demonstrated significant reductions in anxiety scores, improvements in mood, and enhanced cognitive performance including memory and attention. Unlike benzodiazepines, Selank produced anxiolytic effects without sedation, dependency, or withdrawal symptoms — a clinically significant advantage noted by investigators. The compound modulates GABA-ergic transmission and upregulates BDNF in relevant neural circuits, and is registered and approved as a nootropic and anxiolytic pharmaceutical in Russia and Ukraine based on these and subsequent clinical studies.
Selank Improves Memory and Attention in Clinical Populations: Controlled Study Evidence
A controlled clinical study of Selank in patients with cognitive deficit documented significant improvements in verbal memory, logical reasoning, and sustained attention compared to control conditions. Selank’s mechanism — derived from the immunomodulatory peptide tuftsin with an added Pro-Gly-Pro extension conferring CNS stability — was found to influence IL-6 levels and enkephalin metabolism, suggesting a neuroimmune-cognitive pathway alongside its anxiolytic effects. Patient-reported outcomes showed improvements in subjective mental clarity and reduction in fatigue-related cognitive impairment, supporting its use in both anxiety and cognitive enhancement research.